MARATTO

article · Nigerian Journal of Biochemistry and Molecular Biology

Activity of Paullinia pinnata leaf fractions on bacterial isolates associated with treatment-failure wounds

2024Open accessUniversity of Ibadan

Abstract

The current surge of multidrug resistant infections has led to many cases of treatment failure in clinical practices. This has necessitated the search for new drugs from natural sources which could be used to curb this menace. Paullinia pinnata (Linn.) leaves are deployed traditionally for the treatment of various ailments such as malaria and the treatment of wounds. The essence of this study is to assess the antibacterial potential of P. pinnata leaf fractions on four antibiotic-resistant bacteria isolated from treatment failed wounds. The n-hexane and ethyl acetate fractions were obtained from the methanol extract of the leaves of P. pinnata by the one-solvent system fractionation. The antibacterial capacity of the fractions was determined by the agar well diffusion method and gentamicin (30 µg/mL) was the control. Clinical isolates of two Gram-positive (Staphylococcus aureus and Bacillus cereus) and two Gram-negative (Klebsiella pneumoniae and Proteus vulgaris) bacteria were used. The fractions showed no activity to moderate activity at lower concentrations. The ethyl acetate fraction showed bacteriostatic activity in a dose-dependent manner and was better than that of n-hexane, and could therefore be a good drug target for antimicrobial therapies, especially for wound treatment.

Research topics

  • Essential Oils and Antimicrobial Activity
  • Listeria monocytogenes in Food Safety
  • Probiotics and Fermented Foods

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4314/njbmb.v39i1.4

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.